Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression

J. B. Angel, K. G. Parato, A. Kumar, S. Kravcik, Andrew David Badley, C. Fex, D. Ashby, E. Sun, D. W. Cameron

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The degree of immune recovery achievable with anti-human immunodeficiency virus (HIV) therapy remains to be established. The effects of potent antiretroviral therapy, including ritonavir and saquinavir, on immune function were studied for a prolonged period in 41 patients. After 96 weeks, 88% of patients had plasma HIV RNA levels below the limit of quantitation. There were continuous increases in CD4 lymphocyte counts and in CD4:CD8 ratios over time. About half the patients developed lymphoproliferative responses to HIV p24 antigen, and nearly all developed responses to phytohemagglutinin. This occurred in parallel with increases in interleukin-12 production and expression of CD28 on CD8 lymphocytes, despite potential antiproliferative effects of protease inhibitors. Transient increases in virus load were temporally associated with loss of proliferative responses. The improved immune function, including HIV-specific immunity in many subjects, demonstrates the potential reversibility of HIV-induced immunodeficiency and does not identify a limit to immune recovery.

Original languageEnglish (US)
Pages (from-to)546-554
Number of pages9
JournalJournal of Infectious Diseases
Volume183
Issue number4
DOIs
StatePublished - Feb 15 2001
Externally publishedYes

Fingerprint

HIV
Saquinavir
Ritonavir
CD4-CD8 Ratio
Phytohemagglutinins
Interleukin-12
CD4 Lymphocyte Count
Protease Inhibitors
Immunity
Lymphocytes
RNA
Viruses
Antigens
Therapeutics

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression. / Angel, J. B.; Parato, K. G.; Kumar, A.; Kravcik, S.; Badley, Andrew David; Fex, C.; Ashby, D.; Sun, E.; Cameron, D. W.

In: Journal of Infectious Diseases, Vol. 183, No. 4, 15.02.2001, p. 546-554.

Research output: Contribution to journalArticle

Angel, JB, Parato, KG, Kumar, A, Kravcik, S, Badley, AD, Fex, C, Ashby, D, Sun, E & Cameron, DW 2001, 'Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression', Journal of Infectious Diseases, vol. 183, no. 4, pp. 546-554. https://doi.org/10.1086/318547
Angel, J. B. ; Parato, K. G. ; Kumar, A. ; Kravcik, S. ; Badley, Andrew David ; Fex, C. ; Ashby, D. ; Sun, E. ; Cameron, D. W. / Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression. In: Journal of Infectious Diseases. 2001 ; Vol. 183, No. 4. pp. 546-554.
@article{1ff4be9169a442d79cfce43e31ee14b2,
title = "Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression",
abstract = "The degree of immune recovery achievable with anti-human immunodeficiency virus (HIV) therapy remains to be established. The effects of potent antiretroviral therapy, including ritonavir and saquinavir, on immune function were studied for a prolonged period in 41 patients. After 96 weeks, 88{\%} of patients had plasma HIV RNA levels below the limit of quantitation. There were continuous increases in CD4 lymphocyte counts and in CD4:CD8 ratios over time. About half the patients developed lymphoproliferative responses to HIV p24 antigen, and nearly all developed responses to phytohemagglutinin. This occurred in parallel with increases in interleukin-12 production and expression of CD28 on CD8 lymphocytes, despite potential antiproliferative effects of protease inhibitors. Transient increases in virus load were temporally associated with loss of proliferative responses. The improved immune function, including HIV-specific immunity in many subjects, demonstrates the potential reversibility of HIV-induced immunodeficiency and does not identify a limit to immune recovery.",
author = "Angel, {J. B.} and Parato, {K. G.} and A. Kumar and S. Kravcik and Badley, {Andrew David} and C. Fex and D. Ashby and E. Sun and Cameron, {D. W.}",
year = "2001",
month = "2",
day = "15",
doi = "10.1086/318547",
language = "English (US)",
volume = "183",
pages = "546--554",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression

AU - Angel, J. B.

AU - Parato, K. G.

AU - Kumar, A.

AU - Kravcik, S.

AU - Badley, Andrew David

AU - Fex, C.

AU - Ashby, D.

AU - Sun, E.

AU - Cameron, D. W.

PY - 2001/2/15

Y1 - 2001/2/15

N2 - The degree of immune recovery achievable with anti-human immunodeficiency virus (HIV) therapy remains to be established. The effects of potent antiretroviral therapy, including ritonavir and saquinavir, on immune function were studied for a prolonged period in 41 patients. After 96 weeks, 88% of patients had plasma HIV RNA levels below the limit of quantitation. There were continuous increases in CD4 lymphocyte counts and in CD4:CD8 ratios over time. About half the patients developed lymphoproliferative responses to HIV p24 antigen, and nearly all developed responses to phytohemagglutinin. This occurred in parallel with increases in interleukin-12 production and expression of CD28 on CD8 lymphocytes, despite potential antiproliferative effects of protease inhibitors. Transient increases in virus load were temporally associated with loss of proliferative responses. The improved immune function, including HIV-specific immunity in many subjects, demonstrates the potential reversibility of HIV-induced immunodeficiency and does not identify a limit to immune recovery.

AB - The degree of immune recovery achievable with anti-human immunodeficiency virus (HIV) therapy remains to be established. The effects of potent antiretroviral therapy, including ritonavir and saquinavir, on immune function were studied for a prolonged period in 41 patients. After 96 weeks, 88% of patients had plasma HIV RNA levels below the limit of quantitation. There were continuous increases in CD4 lymphocyte counts and in CD4:CD8 ratios over time. About half the patients developed lymphoproliferative responses to HIV p24 antigen, and nearly all developed responses to phytohemagglutinin. This occurred in parallel with increases in interleukin-12 production and expression of CD28 on CD8 lymphocytes, despite potential antiproliferative effects of protease inhibitors. Transient increases in virus load were temporally associated with loss of proliferative responses. The improved immune function, including HIV-specific immunity in many subjects, demonstrates the potential reversibility of HIV-induced immunodeficiency and does not identify a limit to immune recovery.

UR - http://www.scopus.com/inward/record.url?scp=0035865865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035865865&partnerID=8YFLogxK

U2 - 10.1086/318547

DO - 10.1086/318547

M3 - Article

C2 - 11170979

AN - SCOPUS:0035865865

VL - 183

SP - 546

EP - 554

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 4

ER -